TINA YU: Open Payments
NPI 1396420808 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 12 payments from 8 companies in 2025. Trend: 2023 $51 · 2024 $124 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 1 | $90 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| Amgen Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ABBVIE INC. | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
Products named: FARXIGA, VERQUVO, SHINGRIX, CREON, OTEZLA, NEXLETOL, JARDIANCE, EVENITY.
Industry payments across NY — which companies pay providers there.
